Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025 TEL AVIV, Israel, Dec. 20, 2024 (GLOBE...
Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease Teva hosting investor call today at 8:00...
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients Teva to provide two generic inhaler products to Direct Relief for its network of...
Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan Teva entered into an agreement with JKI Co., Ltd. (“JKI”) established by the fund managed and operated by private...
Teva präsentiert positive Wirksamkeits- und Sicherheitsdaten von AJOVY® (Fremanezumab) zur Vorbeugung episodischer Migräne bei Kindern und Jugendlichen aus der Phase-III-Studie SPACE AJOVY®...
Teva présente des données positives sur l’efficacité et la sécurité d’emploi d’AJOVY® (frémanézumab) pour la prévention de la migraine épisodique chez les enfants et les adolescents dans le cadre...
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial AJOVY® (fremanezumab...
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced...
Teva to Present at the Jefferies London Healthcare Conference TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that...
Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 5.35 | 34.1853035144 | 15.65 | 21.6 | 15.55 | 76773 | 20.06263673 | DE |
4 | 4.65 | 28.4403669725 | 16.35 | 21.6 | 15.45 | 24187 | 19.27216224 | DE |
12 | 5.4 | 34.6153846154 | 15.6 | 21.6 | 15.25 | 14405 | 18.0146048 | DE |
26 | 5.15 | 32.4921135647 | 15.85 | 21.6 | 13 | 14241 | 16.87803912 | DE |
52 | 11.54 | 121.987315011 | 9.46 | 21.6 | 9.26 | 18749 | 14.18946623 | DE |
156 | 12.06 | 134.899328859 | 8.94 | 21.6 | 7.58 | 18230 | 13.04540297 | DE |
260 | 12.06 | 134.899328859 | 8.94 | 21.6 | 7.58 | 18230 | 13.04540297 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.